6861.TW Innocare Optoelectronics Corp.
- Market cap
- TWD 7.22B
- P/E
- 27.1x
- P/B
- 4.63x
- ROE
- -
- Dividend yield
- 1.04%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 6861.TW undervalued?
Graham number6861.TW trades 136.3% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Innocare Optoelectronics Corp. fundamental analysis
No fundamental analysis for Innocare Optoelectronics Corp. yet.
Innocare Optoelectronics Corp. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Innocare Optoelectronics Corp.
InnoCare Optoelectronics Corporation engages in the design, development, manufacture, and sale of optical instruments and medical devices. It also offers X-ray flat panel detectors sensors for healthcare, veterinary, security, and industrial applications in Taiwan and internationally. It offers thin film transistors and scintillators, and other medical products, as well as accessories, including power and ethernet cables, charger sets, and batteries. InnoCare Optoelectronics…
Full company profileInnocare Optoelectronics Corp. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Innocare Optoelectronics Corp. annual financial statements
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 433M | 2.34B | 1.94B | 1.89B | 1.84B | 1.99B | 2.29B | 3.23B |
| Gross Profit | 208M | 458M | 526M | 583M | 503M | 552M | 560M | 889M |
| Operating Income | 86.9M | 247M | 234M | 247M | 31.2M | 33.4M | 136M | 392M |
| EBITDA | 94.9M | 205M | 173M | 156M | 112M | 281M | 213M | 440M |
| Net Income | 82.8M | 166M | 199M | 199M | 117M | 153M | 160M | 373M |
| EPS | 2.61 | 5.24 | 5.49 | 5.22 | 2.84 | 3.61 | 3.84 | 8.95 |
| Balance Sheet | ||||||||
| Total Assets | - | 2.03B | 1.70B | 2.00B | 2.27B | 2.37B | 2.58B | - |
| Total Liabilities | 251K | 1.63B | 1.07B | 1.18B | 984M | 989M | 1.12B | - |
| Shareholders' Equity | - | 398M | 637M | 817M | 1.28B | 1.38B | 1.46B | - |
| Cash & Short-term Investments | - | 749M | 459M | 577M | 672M | 795M | 869M | - |
| Total Debt | - | 38.3M | 39.9M | 459M | 191M | 174M | 135M | - |
| Cash Flow | ||||||||
| Operating Cash Flow | - | 441M | -126M | -253M | 109M | 235M | 282M | 90.3M |
| Capital Expenditure | - | 206M | 67.6M | 62.7M | 61.8M | 91.0M | 41.4M | 20.8M |
| Free Cash Flow | - | 235M | -194M | -316M | 47.4M | 144M | 240M | 69.5M |
| Ratios | ||||||||
| ROE | - | 41.8% | 31.2% | 24.3% | 9.1% | 11.1% | 11.0% | - |
| ROA | - | 8.2% | 11.7% | 9.9% | 5.1% | 6.4% | 6.2% | - |
| Net Profit Margin | 19.1% | 7.1% | 10.2% | 10.5% | 6.4% | 7.7% | 7.0% | 11.5% |
| Debt to Equity | - | 0.10x | 0.06x | 0.56x | 0.15x | 0.13x | 0.09x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Innocare Optoelectronics Corp. dividends
- Dividend yield
- 1.04%
- Forward dividend
- 2.00 TWD
- Payout ratio
- 46.9%
- Ex-dividend date
- Jun 15, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | TWD 74.8M | 1.80 | 46.9% |
| 2024 | TWD 44.3M | 1.05 | 29.0% |
| 2023 | TWD 51.2M | 1.25 | 43.9% |
| 2022 | TWD 38.5M | 1.01 | 19.4% |
| 2021 | - | - | - |
| 2020 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Innocare Optoelectronics Corp.
- Insiders 61.27%
- Institutions 0.12%
- Public & others 38.62%
- Shares outstanding 41.6M
- Free float 19.6M
Innocare Optoelectronics Corp. company profile
- Company name
- Innocare Optoelectronics Corp.
- Ticker
- 6861.TW
- Exchange
- Taiwan Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- December
- Address
- No. 2, Southern Taiwan Science Park, Tainan City, Taiwan, 74144
- Phone
- 886 6 700 7238
- Website
- innocare-x.com
About Innocare Optoelectronics Corp.
InnoCare Optoelectronics Corporation engages in the design, development, manufacture, and sale of optical instruments and medical devices. It also offers X-ray flat panel detectors sensors for healthcare, veterinary, security, and industrial applications in Taiwan and internationally. It offers thin film transistors and scintillators, and other medical products, as well as accessories, including power and ethernet cables, charger sets, and batteries. InnoCare Optoelectronics Corporation was founded in 2019 and is headquartered in Tainan City, Taiwan.
Innocare Optoelectronics Corp. management
2- Eric LeePresident
- Ivy ChengFinance & Accounting Manager